Changchun BCHT Biotechnology Co. (SHA:688276)

Market Cap	9.33B
Revenue (ttm)	1.61B
Net Income (ttm)	414.29M
Shares Out	413.66M
EPS (ttm)	1.00
PE Ratio	22.55
Forward PE	12.74
Dividend	0.15 (0.67%)
Ex-Dividend Date	May 24, 2024

Volume	2,807,869
Average Volume	2,461,354
Open	22.75
Previous Close	22.75
Day's Range	22.64 - 23.25
52-Week Range	21.18 - 45.98
Beta	-0.00
RSI	40.74
Earnings Date	Apr 21, 2025

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,241
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688276

Financial Performance

In 2023, SHA:688276's revenue was 1.82 billion, an increase of 70.30% compared to the previous year's 1.07 billion. Earnings were 501.01 million, an increase of 175.98%.